Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)

NCT00289991 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

489

Enrollment

INDUSTRY

Sponsor class

Conditions

Antifungal Prophylaxis of Invasive Fungal Infections

Interventions

DRUG: Itraconazole
DRUG: Vfend - voriconazole

Sponsor

Pfizer